Literature DB >> 27770619

Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects.

Moushira E Zaki1, Hala T El-Bassyouni2, Angie M S Tosson3, Eman Youness4, Jihan Hussein4.   

Abstract

OBJECTIVE: Evidence of oxidative stress was reported in individuals with Down syndrome. There is a growing interest in the contribution of the immune system in Down syndrome. The aim of this study is to evaluate the coenzyme Q10 and selected pro-inflammatory markers such as interleukin 6 and tumor necrosis factor α in children with Down syndrome.
METHODS: Eighty-six children (5-8 years of age) were enrolled in this case-control study from two public institutions. At the time of sampling, the patients and controls suffered from no acute or chronic illnesses and received no therapies or supplements. The levels of interleukin 6, tumor necrosis factor α, coenzyme Q10, fasting blood glucose, and intelligence quotient were measured.
RESULTS: Forty-three young Down syndrome children and forty-three controls were included over a period of eight months (January-August 2014). Compared with the control group, the Down syndrome patients showed significant increase in interleukin 6 and tumor necrosis factor α (p=0.002), while coenzyme Q10 was significantly decreased (p=0.002). Also, body mass index and fasting blood glucose were significantly increased in patients. There was a significantly positive correlation between coenzyme Q10 and intelligence quotient levels, as well as between interleukin 6 and tumor necrosis factor α.
CONCLUSION: Interleukin 6 and tumor necrosis factor α levels in young children with Down syndrome may be used as biomarkers reflecting the neurodegenerative process in them. Coenzyme Q10 might have a role as a good supplement in young children with Down syndrome to ameliorate the neurological symptoms.
Copyright © 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Coenzima Q10; Coenzyme Q10; Crianças com síndrome de Down; Down syndrome children; Estresse oxidativo; Fator de necrose tumoral α; Interleucina 6; Interleukin 6; Oxidative stress; Tumor necrosis factor α

Mesh:

Substances:

Year:  2016        PMID: 27770619     DOI: 10.1016/j.jped.2016.04.012

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  9 in total

1.  Prevalence of celiac disease in patients with Down syndrome: a meta-analysis.

Authors:  Yang Du; Ling-Fei Shan; Zong-Ze Cao; Jin-Chao Feng; Yong Cheng
Journal:  Oncotarget       Date:  2017-12-23

2.  Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis.

Authors:  Yan Zhang; Meng Che; Jing Yuan; Yun Yu; Chang Cao; Xiao-Yan Qin; Yong Cheng
Journal:  Oncotarget       Date:  2017-09-19

3.  Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.

Authors:  Carla M Startin; Nicholas J Ashton; Sarah Hamburg; Rosalyn Hithersay; Frances K Wiseman; Kin Y Mok; John Hardy; Alberto Lleó; Simon Lovestone; Lucilla Parnetti; Henrik Zetterberg; Abdul Hye; André Strydom
Journal:  Alzheimers Res Ther       Date:  2019-03-21       Impact factor: 6.982

4.  Altered Toll-Like Receptor Signalling in Children with Down Syndrome.

Authors:  Dean Huggard; W J Koay; Lynne Kelly; Fiona McGrane; Emer Ryan; Niamh Lagan; Edna Roche; Joanne Balfe; T Ronan Leahy; Orla Franklin; Ana Moreno-Oliveira; Ashanty M Melo; Derek G Doherty; Eleanor J Molloy
Journal:  Mediators Inflamm       Date:  2019-09-12       Impact factor: 4.711

Review 5.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

Review 6.  Down syndrome, accelerated aging and immunosenescence.

Authors:  Noémie Gensous; Maria Giulia Bacalini; Claudio Franceschi; Paolo Garagnani
Journal:  Semin Immunopathol       Date:  2020-07-23       Impact factor: 9.623

Review 7.  Coenzyme Q10 Supplementation in Aging and Disease.

Authors:  Juan D Hernández-Camacho; Michel Bernier; Guillermo López-Lluch; Plácido Navas
Journal:  Front Physiol       Date:  2018-02-05       Impact factor: 4.566

8.  Interleukin 6 and 10 Serum Levels and Genetic Polymorphisms in Children with Down Syndrome.

Authors:  Marlon Fraga Mattos; Patrícia Matos Biselli-Chicote; Joice Matos Biselli; Thiago Luís da Silva Assembleia; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2018-08-16       Impact factor: 4.711

9.  Neuroinflammatory Markers in the Serum of Prepubertal Children with Down Syndrome.

Authors:  Luigi Tarani; Valentina Carito; Giampiero Ferraguti; Carla Petrella; Antonio Greco; Massimo Ralli; Marisa Patrizia Messina; Debora Rasio; Enrica De Luca; Carolina Putotto; Paolo Versacci; Mauro Ceccanti; Marco Fiore
Journal:  J Immunol Res       Date:  2020-03-23       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.